William C. Fanslow

16.2k total citations · 6 hit papers
108 papers, 13.1k citations indexed

About

William C. Fanslow is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, William C. Fanslow has authored 108 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Immunology, 26 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Oncology. Recurrent topics in William C. Fanslow's work include Immune Cell Function and Interaction (52 papers), T-cell and B-cell Immunology (51 papers) and Immunotherapy and Immune Responses (35 papers). William C. Fanslow is often cited by papers focused on Immune Cell Function and Interaction (52 papers), T-cell and B-cell Immunology (51 papers) and Immunotherapy and Immune Responses (35 papers). William C. Fanslow collaborates with scholars based in United States, Canada and United Kingdom. William C. Fanslow's co-authors include Richard J. Armitage, Melanie K. Spriggs, Brian M. Macduff, Sally Painter, David Cosman, L Strockbine, Mark R. Alderson, Richard Armitage, K N Clifford and Wilson Chin and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

William C. Fanslow

107 papers receiving 12.6k citations

Hit Papers

ULBPs, Novel MHC Class I–... 1992 2026 2003 2014 2001 1992 1995 1995 1993 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor
    2001 982 citations David Cosman, Jürgen Müllberg et al. Immunity profile →
  2. Molecular and biological characterization of a murine ligand for CD40
    1992 875 citations Richard J. Armitage, William C. Fanslow et al. Nature profile →
  3. Human IL-17: a novel cytokine derived from T cells
    1995 836 citations Sally Painter, William C. Fanslow et al. The Journal of Immunology profile →
  4. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
    1995 802 citations Zhengbin Yao, William C. Fanslow et al. Immunity profile →
  5. CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome
    1993 654 citations Richard J. Armitage, William C. Fanslow et al. Science profile →
  6. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.
    1993 508 citations Mark R. Alderson, Richard J. Armitage et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William C. Fanslow United States 58 9.6k 2.3k 2.3k 1.3k 1.0k 108 13.1k
Jonathon D. Sedgwick Australia 56 10.5k 1.1× 2.6k 1.1× 2.0k 0.9× 1.5k 1.1× 516 0.5× 98 15.0k
Richard A. Kroczek Germany 54 9.2k 1.0× 2.2k 1.0× 2.1k 0.9× 975 0.8× 682 0.7× 103 12.5k
Iqbal S. Grewal United States 56 7.7k 0.8× 2.3k 1.0× 2.0k 0.9× 837 0.7× 1.3k 1.2× 125 10.8k
Richard J. Armitage United States 45 7.1k 0.7× 1.8k 0.8× 1.6k 0.7× 835 0.7× 712 0.7× 75 9.3k
Otto Majdic Austria 59 6.8k 0.7× 1.9k 0.8× 2.5k 1.1× 648 0.5× 887 0.8× 192 10.5k
Jean‐Yves Bonnefoy France 54 6.1k 0.6× 1.3k 0.6× 2.3k 1.0× 1.3k 1.0× 1.1k 1.1× 152 10.5k
Martin E. Dorf United States 55 8.8k 0.9× 2.5k 1.1× 2.6k 1.2× 836 0.7× 1.9k 1.8× 244 12.3k
Carola G. Vinuesa Australia 54 11.2k 1.2× 1.7k 0.8× 2.9k 1.3× 992 0.8× 833 0.8× 117 14.8k
J A Ledbetter United States 52 9.4k 1.0× 2.0k 0.9× 3.2k 1.4× 703 0.5× 2.1k 2.0× 99 12.7k
B Perussia United States 63 10.5k 1.1× 2.5k 1.1× 3.0k 1.3× 1.3k 1.0× 1.7k 1.7× 132 14.3k

Countries citing papers authored by William C. Fanslow

Since Specialization
Citations

This map shows the geographic impact of William C. Fanslow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William C. Fanslow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William C. Fanslow more than expected).

Fields of papers citing papers by William C. Fanslow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William C. Fanslow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William C. Fanslow. The network helps show where William C. Fanslow may publish in the future.

Co-authorship network of co-authors of William C. Fanslow

This figure shows the co-authorship network connecting the top 25 collaborators of William C. Fanslow. A scholar is included among the top collaborators of William C. Fanslow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William C. Fanslow. William C. Fanslow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamblett, Kevin J., Carl J. Kozlosky, Sophia Siu, et al.. (2015). AMG 595, an Anti-EGFRvIII Antibody–Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma. Molecular Cancer Therapeutics. 14(7). 1614–1624. 82 indexed citations
2.
Hamblett, Kevin J., Allison P. Jacob, Jesse L. Gurgel, et al.. (2015). SLC46A3 Is Required to Transport Catabolites of Noncleavable Antibody Maytansine Conjugates from the Lysosome to the Cytoplasm. Cancer Research. 75(24). 5329–5340. 90 indexed citations
3.
Yao, Zhengbin, William C. Fanslow, Michael F. Seldin, et al.. (2011). Pillars Article: Herpesvirus Saimiri Encodes a New Cytokine, IL-17, which Binds to a Novel Cytokine Receptor. Immunity. 1995. 3: 811–821. The Journal of Immunology. 187(9). 4392–4402. 8 indexed citations
4.
Smedt, Thibaut De, Jeffrey L. Smith, Peter Baum, et al.. (2002). Ox40 Costimulation Enhances the Development of T Cell Responses Induced by Dendritic Cells In Vivo. The Journal of Immunology. 168(2). 661–670. 77 indexed citations
5.
Cosman, David, Jürgen Müllberg, Claire L. Sutherland, et al.. (2001). ULBPs, Novel MHC Class I–Related Molecules, Bind to CMV Glycoprotein UL16 and Stimulate NK Cytotoxicity through the NKG2D Receptor. Immunity. 14(2). 123–133. 982 indexed citations breakdown →
6.
Borges, Luís, Robert E. Miller, Jon Jones, et al.. (1999). Synergistic Action of fms-Like Tyrosine Kinase 3 Ligand and CD40 Ligand in the Induction of Dendritic Cells and Generation of Antitumor Immunity In Vivo. The Journal of Immunology. 163(3). 1289–1297. 44 indexed citations
7.
Campos‐Neto, Antonio, Pamela J. Ovendale, Teresa Bement, et al.. (1998). Cutting Edge: CD40 Ligand Is Not Essential for the Development of Cell-Mediated Immunity and Resistance to Mycobacterium tuberculosis. The Journal of Immunology. 160(5). 2037–2041. 64 indexed citations
8.
Grillot, Didier, Ramón Merino, J C Pena, et al.. (1996). bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice.. The Journal of Experimental Medicine. 183(2). 381–391. 166 indexed citations
9.
Spiegelberg, Hans L., Lucinda Beck, H.P. Kocher, William C. Fanslow, & Alexander H. Lucas. (1994). Role of interleukin-4 in human immunoglobulin E formation in hu-PBL-SCID mice.. Journal of Clinical Investigation. 93(2). 711–717. 31 indexed citations
10.
Ramsdell, Fred, Michael S. Seaman, K N Clifford, & William C. Fanslow. (1994). CD40 ligand acts as a costimulatory signal for neonatal thymic gamma delta T cells.. The Journal of Immunology. 152(5). 2190–2197. 17 indexed citations
11.
Spriggs, Melanie K., William C. Fanslow, Richard J. Armitage, & John W. Belmont. (1993). The biology of the human ligand for CD40. Journal of Clinical Immunology. 13(6). 373–380. 30 indexed citations
12.
Jacobs, Cindy, M P Beckmann, K M Mohler, et al.. (1993). Pharmacokinetic Parameters and Biodistribution of Soluble Cytokine Receptors. PubMed. 34 Pt B. 123–135. 32 indexed citations
13.
Fanslow, William C., Dirk Anderson, Kenneth H. Grabstein, et al.. (1992). Soluble forms of CD40 inhibit biologic responses of human B cells. The Journal of Immunology. 149(2). 655–660. 138 indexed citations
14.
Spriggs, Melanie K., Beverly H. Koller, Takeo Sato, et al.. (1992). Beta 2-microglobulin-, CD8+ T-cell-deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses.. Proceedings of the National Academy of Sciences. 89(13). 6070–6074. 139 indexed citations
15.
Armitage, Richard J., William C. Fanslow, L Strockbine, et al.. (1992). Molecular and biological characterization of a murine ligand for CD40. Nature. 357(6373). 80–82. 875 indexed citations breakdown →
16.
Armitage, Richard J., Timothy A. Sato, Brian M. Macduff, et al.. (1992). Identification of a source of biologically active CD40 ligand. European Journal of Immunology. 22(8). 2071–2076. 68 indexed citations
17.
Fanslow, William C., John E. Sims, Helmut M. Sassenfeld, et al.. (1990). Regulation of Alloreactivity in Vivo by a Soluble Form of the Interleukin-1 Receptor. Science. 248(4956). 739–742. 205 indexed citations
18.
Fanslow, William C., K N Clifford, Tim VandenBos, et al.. (1990). A soluble form of the interleukin 4 receptor in biological fluids. Cytokine. 2(6). 398–401. 35 indexed citations
19.
Buren, Charles T. Van, et al.. (1990). Reversal of immunosuppression induced by a protein-free diet. Critical Care Medicine. 18(Supplement). S118–S118. 29 indexed citations
20.
Kulkarni, Anil D., William C. Fanslow, Frederick B. Rudolph, & Charles T. Van Buren. (1986). Effect of Dietary Nucleotides on Response to Bacterial Infections. Journal of Parenteral and Enteral Nutrition. 10(2). 169–171. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathon D. Sedgwick Breakdown of academic impact, for papers by Richard A. Kroczek Breakdown of academic impact, for papers by Iqbal S. Grewal Breakdown of academic impact, for papers by Richard J. Armitage Breakdown of academic impact, for papers by Otto Majdic Breakdown of academic impact, for papers by Jean‐Yves Bonnefoy Breakdown of academic impact, for papers by Martin E. Dorf Breakdown of academic impact, for papers by Carola G. Vinuesa Breakdown of academic impact, for papers by J A Ledbetter Breakdown of academic impact, for papers by B Perussia
Rankless by CCL
2026